Show an ad over header. AMP

I am the FIRST!!!

The labs handling coronavirus testing for pro sports leagues

The NFL, NBA and MLS have all enlisted the same company, BioReference Laboratories, to handle coronavirus testing during their respective restarts.

The big picture: Coronavirus testing in sports has become a hot-button issue, with some concerned that leagues are consuming limited resources while many Americans either can't get tested or have to wait too long for results.


  • BioReference chairman Jon Cohen pushed back against that narrative, saying the company's work with sports leagues hasn't impacted its ability to test the general public in Florida and other states where it has facilities.
  • "Our current capacity is somewhere in the vicinity of 50,000 to 70,000 tests a day," he told The Athletic's Joe Vardon (subscription). "So the amount of testing we're doing for the sports franchises is minimal compared to our total testing."

NFL: testing will reportedly cost around $75 million, and will be evenly paid for by all 32 teams. The fee includes 120 tests per team per day, with the option to add additional tests for $125 each.

  • NBA: Players receive both a nasal and saliva swab every other day, administered by the ~100 BioReference employees living in the bubble. The samples are driven 75 minutes away to a lab in Melbourne, Florida, for analysis.
  • MLS: Like its Disney World counterpart, players are tested every other day. There hasn't been a positive test among the 24 participating clubs since July 10. Tests take 12–15 hours to process.
Data: Yahoo Finance; Chart: Axios Visuals

The impact: Shares in BioReference's parent company, OPKO Health, are up nearly 300% since the start of the year, and the stock has surged since testing began in the NBA and MLS bubbles.

Other testing partners:

regular 4 post ff

infinite scroll 4 pff

Biden campaign resumes negative ads against Trump

Joe Biden's campaign has resumed its negative TV and digital ads against President Trump after temporarily taking them down last Friday when he was hospitalized with COVID-19.

Why it matters: There are just under four weeks until the election. Now that Trump is back in the White House, Democrats feel he's fair game for criticism as he was before his diagnosis.

Keep reading...Show less

Billionaire philanthropist Robert Smith's tax fraud roils Vista Equity

Robert Smith's admission to tax fraud has done more than just cost him a whopping $140 million. It's also roiled Vista Equity Partners, the private equity firm he founded and leads, with some insiders and limited partners feeling they were misled (or left in the dark) about the extent of Smith's legal troubles.

Behind the scenes: Smith called a virtual meeting of Vista's managing directors and other top staffers on Wednesday, to discuss details of his settlement. A source says he called the overall experience "humbling" and that he regretted the "undue burden" that his actions had put on others, including some Vista colleagues.

Keep reading...Show less

As birth rates fall in the U.S., reproductive technology is entering a brave new world

As the U.S. fertility rate falls to a 35-year-low, new technologies promise to radically change how we have babies.

Why it matters: The demand for assisted reproductive technology like IVF is likely to grow as people delay the decision to have children. But newer advances in gene editing and diagnostic testing could open the door for a revolution in reproduction, raising ethical questions we haven't begun to answer.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;